These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 34792153)

  • 1. Decreasing Incidence and Determinants of Bacterial Pneumonia in People With HIV: The Swiss HIV Cohort Study.
    Balakrishna S; Wolfensberger A; Kachalov V; Roth JA; Kusejko K; Scherrer AU; Furrer H; Hauser C; Calmy A; Cavassini M; Schmid P; Bernasconi E; Battegay M; Günthard HF; Kouyos RD;
    J Infect Dis; 2022 May; 225(9):1592-1600. PubMed ID: 34792153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial pneumonia among HIV-infected patients: decreased risk after tobacco smoking cessation. ANRS CO3 Aquitaine Cohort, 2000-2007.
    Bénard A; Mercié P; Alioum A; Bonnet F; Lazaro E; Dupon M; Neau D; Dabis F; Chêne G;
    PLoS One; 2010 Jan; 5(1):e8896. PubMed ID: 20126646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study.
    Kohli R; Lo Y; Homel P; Flanigan TP; Gardner LI; Howard AA; Rompalo AM; Moskaleva G; Schuman P; Schoenbaum EE;
    Clin Infect Dis; 2006 Jul; 43(1):90-8. PubMed ID: 16758423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015.
    Sun J; Althoff KN; Jing Y; Horberg MA; Buchacz K; Gill MJ; Justice AC; Rabkin CS; Goedert JJ; Sigel K; Cachay E; Park L; Lim JK; Kim HN; Lo Re V; Moore R; Sterling T; Peters MG; Achenbach CJ; Silverberg M; Thorne JE; Mayor AM; Crane HM; Kitahata MM; Klein M; Kirk GD;
    JAMA Netw Open; 2021 Feb; 4(2):e2037512. PubMed ID: 33595662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, timing, and determinants of bacterial pneumonia among HIV-infected patients: data from the ICONA Foundation Cohort.
    Mussini C; Galli L; Lepri AC; De Luca A; Antinori A; Libertone R; Angarano G; Bonfanti P; Castagna A; DʼArminio Monforte A;
    J Acquir Immune Defic Syndr; 2013 Jul; 63(3):339-45. PubMed ID: 23591636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.
    Ledergerber B; Egger M; Erard V; Weber R; Hirschel B; Furrer H; Battegay M; Vernazza P; Bernasconi E; Opravil M; Kaufmann D; Sudre P; Francioli P; Telenti A
    JAMA; 1999 Dec; 282(23):2220-6. PubMed ID: 10605973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial pneumonia in HIV-infected patients: use of the pneumonia severity index and impact of current management on incidence, aetiology and outcome.
    Curran A; Falcó V; Crespo M; Martinez X; Ribera E; Villar del Saz S; Imaz A; Coma E; Ferrer A; Pahissa A
    HIV Med; 2008 Oct; 9(8):609-15. PubMed ID: 18557951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of antiretroviral therapy on the incidence of bacterial pneumonia in patients with advanced HIV infection.
    Sullivan JH; Moore RD; Keruly JC; Chaisson RE
    Am J Respir Crit Care Med; 2000 Jul; 162(1):64-7. PubMed ID: 10903221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of bacterial pneumonia in Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT).
    Pett SL; Carey C; Lin E; Wentworth D; Lazovski J; Miró JM; Gordin F; Angus B; Rodriguez-Barradas M; Rubio R; Tambussi G; Cooper DA; Emery S;
    HIV Med; 2011 Apr; 12(4):219-27. PubMed ID: 20812949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumonia in HIV-infected patients in the HAART era: incidence, risk, and impact of the pneumococcal vaccination.
    López-Palomo C; Martín-Zamorano M; Benítez E; Fernández-Gutiérrez C; Guerrero F; Rodríguez-Iglesias M; Girón-González JA
    J Med Virol; 2004 Apr; 72(4):517-24. PubMed ID: 14981752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study.
    Sogaard OS; Lohse N; Gerstoft J; Kronborg G; Ostergaard L; Pedersen C; Pedersen G; Sørensen HT; Obel N
    Clin Infect Dis; 2008 Nov; 47(10):1345-53. PubMed ID: 18834317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and Determinants of Long-Term Immune Recovery Under Suppressive Antiretroviral Therapy.
    Turk T; Labarile M; Braun DL; Rauch A; Stöckle M; Cavassini M; Hoffmann M; Calmy A; Bernasconi E; Notter J; Pasin C; Günthard HF; Kouyos RD;
    J Acquir Immune Defic Syndr; 2024 May; 96(1):68-76. PubMed ID: 38301637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?
    ; Mocroft A; Reiss P; Kirk O; Mussini C; Girardi E; Morlat P; Stephan C; De Wit S; Doerholt K; Ghosn J; Bucher HC; Lundgren JD; Chene G; Miro JM; Furrer H
    Clin Infect Dis; 2010 Sep; 51(5):611-9. PubMed ID: 20645862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.
    del Amo J; Moreno S; Bucher HC; Furrer H; Logan R; Sterne J; Pérez-Hoyos S; Jarrín I; Phillips A; Lodi S; van Sighem A; de Wolf W; Sabin C; Bansi L; Justice A; Goulet J; Miró JM; Ferrer E; Meyer L; Seng R; Toulomi G; Gargalianos P; Costagliola D; Abgrall S; Hernán MA;
    Clin Infect Dis; 2012 May; 54(9):1364-72. PubMed ID: 22460971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study.
    Khanna N; Elzi L; Mueller NJ; Garzoni C; Cavassini M; Fux CA; Vernazza P; Bernasconi E; Battegay M; Hirsch HH;
    Clin Infect Dis; 2009 May; 48(10):1459-66. PubMed ID: 19348592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
    Kaufmann GR; Furrer H; Ledergerber B; Perrin L; Opravil M; Vernazza P; Cavassini M; Bernasconi E; Rickenbach M; Hirschel B; Battegay M;
    Clin Infect Dis; 2005 Aug; 41(3):361-72. PubMed ID: 16007534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does enfuvirtide increase the risk of bacterial pneumonia in patients receiving combination antiretroviral therapy?
    Kousignian I; Launay O; Mayaud C; Rabaud C; Costagliola D; Abgrall S;
    J Antimicrob Chemother; 2010 Jan; 65(1):138-44. PubMed ID: 19903719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy.
    Polesel J; Clifford GM; Rickenbach M; Dal Maso L; Battegay M; Bouchardy C; Furrer H; Hasse B; Levi F; Probst-Hensch NM; Schmid P; Franceschi S;
    AIDS; 2008 Jan; 22(2):301-6. PubMed ID: 18097233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study.
    Hasse B; Ledergerber B; Furrer H; Battegay M; Hirschel B; Cavassini M; Bertisch B; Bernasconi E; Weber R;
    Clin Infect Dis; 2011 Dec; 53(11):1130-9. PubMed ID: 21998280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV viral load as an independent risk factor for tuberculosis in South Africa: collaborative analysis of cohort studies.
    Fenner L; Atkinson A; Boulle A; Fox MP; Prozesky H; Zürcher K; Ballif M; Furrer H; Zwahlen M; Davies MA; Egger M;
    J Int AIDS Soc; 2017 Jun; 20(1):21327. PubMed ID: 28691438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.